Iovance Biotherapeutics I... (IOVA)
NASDAQ: IOVA
· Real-Time Price · USD
2.54
0.09 (3.67%)
At close: Aug 15, 2025, 3:59 PM
2.55
0.20%
After-hours: Aug 15, 2025, 07:57 PM EDT
Iovance Biotherapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 132.47M | 171.67M | 115.69M | 164.19M | 228.75M | 134.19M | 114.89M | 267.72M | 230.01M | 543.48M | 231.73M | 118.37M | 108.08M | 92.36M | 78.23M | 58.59M | 82.76M | 131.95M |
Short-Term Investments | 168.71M | 188.04M | 208.09M | 233.3M | 183.86M | 222.01M | 164.98M | 93.65M | 20.88M | 82.81M | 240.11M | 241.81M | 316.38M | 389.83M | 426.18M | 517.86M | 573.61M | 461.98M |
Long-Term Investments | n/a | n/a | n/a | 6.36M | 6.36M | 6.43M | 66.43M | n/a | 66.43M | 6.43M | 6.43M | n/a | 6.43M | 27.7M | 91.59M | 78.25M | 46.29M | 10.23M |
Other Long-Term Assets | 16.26M | 6.25M | 6.73M | 280K | 327K | 259K | 270K | 133.14M | 66.72M | 202K | -178.25M | 7.03M | 856K | 7.35M | 7.87M | 7.09M | 7.23M | 7.25M |
Receivables | 59.94M | 70.94M | 69.34M | 55.77M | 31.6M | 234K | 151K | n/a | 33K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | 49.83M | 65.55M | 51.52M | 38.58M | 27.85M | 17.62M | 10.37M | 9.2M | 9.72M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 11.55M | 16.45M | 12.38M | 6.74M | 10.18M | 11.49M | 17.46M | 12.02M | 14.23M | 11.49M | 7.27M | 9.71M | 7.13M | 7.78M | 3.55M | 6.58M | 10.27M | 11.29M |
Total Current Assets | 422.5M | 512.65M | 457.02M | 498.58M | 482.26M | 385.53M | 307.85M | 382.59M | 274.88M | 637.78M | 471.85M | 369.88M | 431.59M | 489.97M | 507.96M | 583.03M | 666.64M | 605.22M |
Property-Plant & Equipment | 172.42M | 162.49M | 164.28M | 179.26M | 180.08M | 183.31M | 176.54M | 179.41M | 180.18M | 180.35M | 178.25M | 169.01M | 172M | 176.23M | 169.92M | 160.46M | 132.63M | 127.88M |
Goodwill & Intangibles | 296.25M | 285.36M | 282.4M | 306.64M | 295.3M | 294.3M | 229.26M | 223.61M | 235.51M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 484.94M | 454.09M | 453.41M | 492.54M | 482.06M | 484.3M | 472.5M | 469.73M | 482.42M | 186.99M | 6.43M | 176.04M | 179.28M | 211.28M | 269.38M | 245.8M | 186.15M | 145.35M |
Total Assets | 907.44M | 966.74M | 910.43M | 991.12M | 964.32M | 869.83M | 780.35M | 852.32M | 757.29M | 824.77M | 663.98M | 545.92M | 610.88M | 701.25M | 777.33M | 828.83M | 852.79M | 750.57M |
Account Payables | 32M | 28.49M | 27.51M | 31.69M | 20.42M | 25.7M | 33.12M | 19.27M | 31.16M | 31.57M | 26.6M | 24.25M | 20.01M | 20.45M | 27.38M | 12.18M | 21.91M | 13.37M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7.17M | n/a | n/a | -5.06M | n/a | n/a | n/a |
Short-Term Debt | 1M | 1M | n/a | n/a | n/a | 11.08M | 7.78M | 10.47M | 10.87M | 12.61M | n/a | 7.17M | 6.48M | 7.71M | n/a | 6.62M | 4.43M | 5.92M |
Other Current Liabilities | n/a | n/a | 50.03M | n/a | 36.81M | -11.08M | 26.82M | 21.93M | 17.39M | 16.57M | n/a | 21.48M | 17.74M | 23M | n/a | 24.19M | 19.55M | 21.96M |
Total Current Liabilities | 129.16M | 122.69M | 122.34M | 118.06M | 93.64M | 83.21M | 110.31M | 90.95M | 88.64M | 87.27M | 91.48M | 79.25M | 64.19M | 77.08M | 89.2M | 64.77M | 60.53M | 55.06M |
Long-Term Debt | n/a | 44.22M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M | 1M |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 79.79M | 76.18M | 77.68M | 99.6M | 102.14M | 106.59M | 85.43M | 87.35M | 90.08M | 70.61M | 84.45M | 72.94M | 74M | 72.18M | 66.47M | 65.73M | 47.84M | 48.08M |
Total Liabilities | 208.95M | 198.88M | 200.02M | 217.66M | 195.78M | 189.81M | 195.74M | 178.31M | 178.72M | 157.89M | 164.34M | 152.19M | 138.19M | 149.26M | 155.67M | 130.5M | 108.38M | 103.14M |
Total Debt | 53.17M | 53.72M | 58.26M | 78.94M | 81.68M | 84.37M | 75.86M | 79.48M | 80.71M | 82.23M | 84.45M | 80.11M | 80.48M | 79.89M | 71.53M | 72.34M | 52.27M | 54M |
Common Stock | 14K | 14K | 13K | 13K | 12K | 12K | 11K | 11K | 9K | 9K | 8K | 7K | 7K | 7K | 7K | 7K | 7K | 6K |
Retained Earnings | -2.61B | -2.5B | -2.38B | -2.31B | -2.22B | -2.13B | -2.01B | -1.9B | -1.78B | -1.68B | -1.57B | -1.46B | -1.36B | -1.26B | -1.17B | -1.07B | -986.99M | -905.64M |
Comprehensive Income | 20.86M | 6.29M | -1.05M | 16.24M | 526K | 116K | 2.53M | -9.1M | 325K | -126K | -902K | -2.04M | -2.7M | -2.34M | -601K | -5K | 33K | 96K |
Shareholders Equity | 698.49M | 767.87M | 710.4M | 773.46M | 768.54M | 680.02M | 584.61M | 674.01M | 578.57M | 666.88M | 499.64M | 393.74M | 472.69M | 551.99M | 621.66M | 698.33M | 744.41M | 647.43M |
Total Investments | 168.71M | 188.04M | 208.09M | 233.3M | 190.22M | 228.44M | 231.41M | 93.65M | 20.88M | 82.81M | 240.11M | 241.81M | 316.38M | 417.53M | 517.77M | 596.11M | 619.89M | 472.2M |